P01909 (DQA1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 131.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: HLA class II histocompatibility antigen, DQ alpha 1 chain Alternative name(s): DC-1 alpha chain DC-alpha HLA-DCA MHC class II DQA1 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 254 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal miroenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading. |
| Subunit structure | Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmic reticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariant chain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoes sequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHC class II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding of antigenic peptides. Ref.40 Ref.41 Ref.42 Ref.43 |
| Subcellular location | Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-pass type I membrane protein. Golgi apparatus › trans-Golgi network membrane; Single-pass type I membrane protein. Endosome membrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Note: The MHC class II complex transits through a number of intracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation. |
| Polymorphism | The following alleles of DQA1 are known: DQA1*01:01, DQA1*01:02, DQA1*01:03, DQA1*01:04, DQA1*01:05, DQA1*01:06, DQA1*01:07, DQA1*02:01, DQA1*03:01, DQA1*03:02, DQA1*03:03, DQA1*04:01, DQA1*04:02, DQA1*04:03, DQA1*04:04, DQA1*05:01, DQA1*05:02, DQA1*05:03, DQA1*05:04, DQA1*05:05, DQA1*05:06, DQA1*05:07, DQA1*05:08, DQA1*05:09, DQA1*06:01, DQA1*06:02. The sequence shown is that of DQA1*05:01. DQ2 (heterodimer of DQA1*05:01/DQB1*02:01) is associated with more than 90% of celiac disease patients. A minority displays DQ8 (heterodimer of DQA1*03/DQB1*03:02). DQ0602 (heterodimer of DQA1*01:02/DQB1*06:02) confers dominant protection against type 1 diabetes (T1D) and strong susceptibility to narcolepsy. |
| Sequence similarities | Belongs to the MHC class II family. Contains 1 Ig-like C1-type (immunoglobulin-like) domain. |
| Sequence caution | The sequence AAD56720.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 23 | 23 | Ref.20 | ||||||||||||||||||||||||||||||||||||
| Chain | 24 – 254 | 231 | HLA class II histocompatibility antigen, DQ alpha 1 chain | PRO_0000018970 | |||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||
| Topological domain | 24 – 216 | 193 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 217 – 239 | 23 | Helical; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 240 – 254 | 15 | Cytoplasmic | ||||||||||||||||||||||||||||||||||||
| Domain | 112 – 204 | 93 | Ig-like C1-type | ||||||||||||||||||||||||||||||||||||
| Region | 24 – 119 | 96 | Alpha-1 | ||||||||||||||||||||||||||||||||||||
| Region | 120 – 203 | 84 | Alpha-2 | ||||||||||||||||||||||||||||||||||||
| Region | 204 – 216 | 13 | Connecting peptide | ||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 103 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 143 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 132 ↔ 188 | Ref.40 Ref.41 Ref.43 | |||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 8 | 1 | M → L in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*04:01 and allele DQA1*06:01. Corresponds to variant rs1047989 [ dbSNP | Ensembl ]. | VAR_033399 | |||||||||||||||||||||||||||||||||||
| Natural variant | 11 | 1 | A → T in allele DQA1*05:05, allele DQA1*05:08 and allele DQA1*05:09. Corresponds to variant rs1047992 [ dbSNP | Ensembl ]. | VAR_033400 | |||||||||||||||||||||||||||||||||||
| Natural variant | 17 | 1 | V → M in allele DQA1*01:04 and allele DQA1*01:05. Corresponds to variant rs12722039 [ dbSNP | Ensembl ]. | VAR_050380 | |||||||||||||||||||||||||||||||||||
| Natural variant | 18 | 1 | M → T in allele DQA1*03:03. Corresponds to variant rs12722040 [ dbSNP | Ensembl ]. | VAR_050381 | |||||||||||||||||||||||||||||||||||
| Natural variant | 24 | 1 | E → K in allele DQA1*05:09. Corresponds to variant rs41545012 [ dbSNP | Ensembl ]. | VAR_060493 | |||||||||||||||||||||||||||||||||||
| Natural variant | 25 | 1 | D → G in allele DQA1*01:04 and allele DQA1*01:05. Corresponds to variant rs12722042 [ dbSNP | Ensembl ]. | VAR_050382 | |||||||||||||||||||||||||||||||||||
| Natural variant | 34 | 1 | Y → C in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07. Corresponds to variant rs1129740 [ dbSNP | Ensembl ]. | VAR_060494 | |||||||||||||||||||||||||||||||||||
| Natural variant | 41 | 1 | S → F in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07. Corresponds to variant rs1071630 [ dbSNP | Ensembl ]. | VAR_033401 | |||||||||||||||||||||||||||||||||||
| Natural variant | 44 | 1 | P → L in allele DQA1*05:04. Corresponds to variant rs41549715 [ dbSNP | Ensembl ]. | VAR_060495 | |||||||||||||||||||||||||||||||||||
| Natural variant | 48 | 1 | Y → F in allele DQA1*02:01, allele DQA1*01:03, allele DQA1*06:01 and allele DQA1*06:02. Corresponds to variant rs12722051 [ dbSNP | Ensembl ]. | VAR_033402 | |||||||||||||||||||||||||||||||||||
| Natural variant | 49 | 1 | T → S in allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03. Corresponds to variant rs3188011 [ dbSNP | Ensembl ]. | VAR_033403 | |||||||||||||||||||||||||||||||||||
| Natural variant | 57 | 1 | Q → E in allele DQA1*01:01, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03. Corresponds to variant rs10093 [ dbSNP | Ensembl ]. | VAR_014604 | |||||||||||||||||||||||||||||||||||
| Natural variant | 63 | 1 | G → E in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06, allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03. Corresponds to variant rs1142323 [ dbSNP | Ensembl ]. | VAR_060496 | |||||||||||||||||||||||||||||||||||
| Natural variant | 64 | 1 | R → K in allele DQA1*01:03. Corresponds to variant rs36219699 [ dbSNP | Ensembl ]. | VAR_050383 | |||||||||||||||||||||||||||||||||||
| Natural variant | 67 | 1 | T → A in allele DQA1*01:06. Corresponds to variant rs41543221 [ dbSNP | Ensembl ]. | VAR_060497 | |||||||||||||||||||||||||||||||||||
| Natural variant | 68 | 1 | V → A in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07. Corresponds to variant rs1142324 [ dbSNP | Ensembl ]. | VAR_060498 | |||||||||||||||||||||||||||||||||||
| Natural variant | 70 | 1 | C → K in allele DQA1*02:01; requires 2 nucleotide substitutions. | VAR_060499 | |||||||||||||||||||||||||||||||||||
| Natural variant | 70 | 1 | C → Q in allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03; requires 2 nucleotide substitutions. | VAR_060500 | |||||||||||||||||||||||||||||||||||
| Natural variant | 70 | 1 | C → R in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07. | VAR_060501 | |||||||||||||||||||||||||||||||||||
| Natural variant | 70 | 1 | C → Y. Corresponds to variant rs3207983 [ dbSNP | Ensembl ]. | VAR_033404 | |||||||||||||||||||||||||||||||||||
| Natural variant | 71 | 1 | L → W in allele DQA1*01:01, allele DQA1*01:02,allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07. Corresponds to variant rs1142328 [ dbSNP | Ensembl ]. | VAR_060502 | |||||||||||||||||||||||||||||||||||
| Natural variant | 73 | 1 | V → D. | VAR_033406 | |||||||||||||||||||||||||||||||||||
| Natural variant | 73 | 1 | V → E in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07. Corresponds to variant rs3208105 [ dbSNP | Ensembl ]. | VAR_060503 | |||||||||||||||||||||||||||||||||||
| Natural variant | 73 | 1 | V → L in allele DQA1*02:01, allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03. | VAR_033405 | |||||||||||||||||||||||||||||||||||
| Natural variant | 74 | 1 | L → F in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06, allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03. Corresponds to variant rs9272698 [ dbSNP | Ensembl ]. | VAR_060504 | |||||||||||||||||||||||||||||||||||
| Natural variant | 75 | 1 | R → H in allele DQA1*02:01. | VAR_060505 | |||||||||||||||||||||||||||||||||||
| Natural variant | 75 | 1 | R → S in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07. Corresponds to variant rs9272699 [ dbSNP | Ensembl ]. | VAR_060506 | |||||||||||||||||||||||||||||||||||
| Natural variant | 76 | 1 | Q → K in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07. Corresponds to variant rs1048052 [ dbSNP | Ensembl ]. | VAR_060507 | |||||||||||||||||||||||||||||||||||
| Natural variant | 76 | 1 | Q → R in allele DQA1*02:01, allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03. | VAR_060508 | |||||||||||||||||||||||||||||||||||
| Natural variant | 77 | 1 | F → L in allele DQA1*02:01. Corresponds to variant rs3188043 [ dbSNP | Ensembl ]. | VAR_060509 | |||||||||||||||||||||||||||||||||||
| Natural variant | 78 | 1 | R → GG in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,allele DQA1*01:06 and allele DQA1*01:07. Corresponds to variant rs4193 [ dbSNP | Ensembl ]. | VAR_060510 | |||||||||||||||||||||||||||||||||||
| Natural variant | 78 | 1 | R → RR in allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03. | VAR_060511 | |||||||||||||||||||||||||||||||||||
| Natural variant | 78 | 1 | R → S. Corresponds to variant rs36219345 [ dbSNP | Ensembl ]. | VAR_033407 | |||||||||||||||||||||||||||||||||||
| Natural variant | 81 | 1 | P → R in allele DQA1*05:02. Corresponds to variant rs41541412 [ dbSNP | Ensembl ]. | VAR_060512 | |||||||||||||||||||||||||||||||||||
| Natural variant | 83 | 1 | F → G in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07; requires 2 nucleotide substitutions. | VAR_060513 | |||||||||||||||||||||||||||||||||||
| Natural variant | 86 | 1 | T → R in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07. Corresponds to variant rs1048073 [ dbSNP | Ensembl ]. | VAR_033408 | |||||||||||||||||||||||||||||||||||
| Natural variant | 88 | 1 | I → M in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07. Corresponds to variant rs1048080 [ dbSNP | Ensembl ]. | VAR_033409 | |||||||||||||||||||||||||||||||||||
| Natural variant | 91 | 1 | L → A in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07; requires 2 nucleotide substitutions. | VAR_060514 | |||||||||||||||||||||||||||||||||||
| Natural variant | 91 | 1 | L → T in allele DQA1*04:01, allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01 and allele DQA1*06:02; requires 2 nucleotide substitutions. | VAR_060515 | |||||||||||||||||||||||||||||||||||
| Natural variant | 91 | 1 | L → V. Corresponds to variant rs1048085 [ dbSNP | Ensembl ]. | VAR_033410 | |||||||||||||||||||||||||||||||||||
| Natural variant | 97 | 1 | S → I in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06, allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01, allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01, allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01 and allele DQA1*06:02. | VAR_060516 | |||||||||||||||||||||||||||||||||||
| Natural variant | 98 | 1 | L → M in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07. | VAR_060517 | |||||||||||||||||||||||||||||||||||
| Natural variant | 98 | 1 | L → V in allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03. | VAR_060518 | |||||||||||||||||||||||||||||||||||
| Natural variant | 101 | 1 | R → C in allele DQA1*01:07. | VAR_060519 | |||||||||||||||||||||||||||||||||||
| Natural variant | 102 | 1 | S → Y in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07. Corresponds to variant rs1129808 [ dbSNP | Ensembl ]. | VAR_050384 | |||||||||||||||||||||||||||||||||||
| Natural variant | 124 | 1 | L → V in allele DQA1*05:06. | VAR_060520 | |||||||||||||||||||||||||||||||||||
| Natural variant | 129 | 1 | I → T in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01, allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01, allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01 and allele DQA1*06:02. Corresponds to variant rs707952 [ dbSNP | Ensembl ]. | VAR_050385 | |||||||||||||||||||||||||||||||||||
| Natural variant | 151 | 1 | H → Q in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:04, allele DQA1*01:05 and allele DQA1*01:07. Corresponds to variant rs707950 [ dbSNP | Ensembl ]. | VAR_050386 | |||||||||||||||||||||||||||||||||||
| Natural variant | 152 | 1 | S → A in allele DQA1*01:03. | VAR_060521 | |||||||||||||||||||||||||||||||||||
| Natural variant | 160 | 1 | T → I in allele DQA1*04:02. | VAR_060522 | |||||||||||||||||||||||||||||||||||
| Natural variant | 161 | 1 | S → I in allele DQA1*05:08. | VAR_060524 | |||||||||||||||||||||||||||||||||||
| Natural variant | 161 | 1 | S → R in allele DQA1*06:02. | VAR_060523 | |||||||||||||||||||||||||||||||||||
| Natural variant | 175 | 1 | Y → H in allele DQA1*04:04. | VAR_060525 | |||||||||||||||||||||||||||||||||||
| Natural variant | 178 | 1 | L → F in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01, allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01, allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01 and allele DQA1*06:02. Corresponds to variant rs707949 [ dbSNP | Ensembl ]. | VAR_060526 | |||||||||||||||||||||||||||||||||||
| Natural variant | 182 | 1 | A → D in allele DQA1*03:02 and allele DQA1*03:03. | VAR_060527 | |||||||||||||||||||||||||||||||||||
| Natural variant | 182 | 1 | A → S in allele DQA1*05:03, allele DQA1*05:06 and allele DQA1*05:07. | VAR_060528 | |||||||||||||||||||||||||||||||||||
| Natural variant | 183 | 1 | E → D in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01, allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01, allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01 and allele DQA1*06:02. Corresponds to variant rs707963 [ dbSNP | Ensembl ]. | VAR_060529 | |||||||||||||||||||||||||||||||||||
| Natural variant | 185 | 1 | S → I in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05, allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01, allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01, allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01 and allele DQA1*06:02. | VAR_060530 | |||||||||||||||||||||||||||||||||||
| Natural variant | 197 | 1 | K → E in allele DQA1*02:01, allele DQA1*03:01, allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01, allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01 and allele DQA1*06:02. | VAR_060531 | |||||||||||||||||||||||||||||||||||
| Natural variant | 197 | 1 | K → Q in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05 and allele DQA1*01:07. | VAR_060532 | |||||||||||||||||||||||||||||||||||
| Natural variant | 209 | 1 | A → T in allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03. Corresponds to variant rs9272785 [ dbSNP | Ensembl ]. | VAR_050387 | |||||||||||||||||||||||||||||||||||
| Natural variant | 221 | 1 | A → T in allele DQA1*01:04. Corresponds to variant rs35087390 [ dbSNP | Ensembl ]. | VAR_050388 | |||||||||||||||||||||||||||||||||||
| Natural variant | 229 | 1 | V → M in allele DQA1*01:02. Corresponds to variant rs9260 [ dbSNP | Ensembl ]. | VAR_033411 | |||||||||||||||||||||||||||||||||||
| Natural variant | 230 | 1 | G → C in allele DQA1*05:07. | VAR_060533 | |||||||||||||||||||||||||||||||||||
| Natural variant | 237 | 1 | F → L in allele DQA1*02:01, allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03. Corresponds to variant rs1048430 [ dbSNP | Ensembl ]. | VAR_033412 | |||||||||||||||||||||||||||||||||||
| Natural variant | 240 | 1 | R → Q in allele DQA1*01:01, allele DQA1*01:02, allele DQA1*01:03, allele DQA1*01:04 and allele DQA1*01:05. Corresponds to variant rs9272793 [ dbSNP | Ensembl ]. | VAR_033413 | |||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 11 | 1 | A → S in AAA59760. Ref.4 | ||||||||||||||||||||||||||||||||||||
| Sequence conflict | 23 – 27 | 5 | Missing in AAA59754. Ref.16 | ||||||||||||||||||||||||||||||||||||
| Sequence conflict | 91 | 1 | L → H in AAA59760. Ref.4 | ||||||||||||||||||||||||||||||||||||
| Sequence conflict | 107 | 1 | A → P in AAA59754. Ref.16 | ||||||||||||||||||||||||||||||||||||
| Sequence conflict | 156 | 1 | G → D in CAA25141. Ref.3 | ||||||||||||||||||||||||||||||||||||
| Sequence conflict | 213 | 1 | E → D in AAA59754. Ref.16 | ||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 29 – 40 | 12 | |||||||||||||||||||||||||||||||||||||
| Turn | 41 – 44 | 4 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 45 – 52 | 8 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 55 – 61 | 7 | |||||||||||||||||||||||||||||||||||||
| Turn | 62 – 65 | 4 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 66 – 71 | 6 | |||||||||||||||||||||||||||||||||||||
| Helix | 72 – 77 | 6 | |||||||||||||||||||||||||||||||||||||
| Helix | 81 – 101 | 21 | |||||||||||||||||||||||||||||||||||||
| Turn | 102 – 104 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 113 – 120 | 8 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 128 – 137 | 10 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 143 – 148 | 6 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 151 – 153 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 157 – 159 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 170 – 178 | 9 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 186 – 191 | 6 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 195 – 197 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 199 – 203 | 5 | |||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The heavy chain of human B-cell alloantigen HLA-DS has a variable N-terminal region and a constant immunoglobulin-like region." Chang H.-C., Moriuchi T., Silver J. Nature 305:813-815(1983) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*02:01). |
| [2] | "Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains." Schenning L., Larhammar D., Bill P., Wiman K., Jonsson A.-K., Rask L., Peterson P.A. EMBO J. 3:447-452(1984) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*05:01). |
| [3] | "Isotypic and allotypic variation of human class II histocompatibility antigen alpha-chain genes." Auffray C., Lillie J.W., Arnot D., Grossberger D., Kappes D., Strominger J.L. Nature 308:327-333(1984) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELES DQA1*01:02 AND ALLELE DQA1*03:01). |
| [4] | "Complete sequence of the HLA DQ alpha and DQ beta cDNA from a DR5/DQw3 cell line." Schiffenbauer J., Didier D.K., Klearman M., Rice K., Shuman S., Tieber V.L., Kittlesen D.J., Schwartz B.D. J. Immunol. 139:228-233(1987) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*05:01). |
| [5] | "HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy." Ellis M.C., Hetisimer A.H., Ruddy D.A., Hansen S.L., Kronmal G.S., McClelland E., Quintana L., Drayna D.T., Aldrich M.S., Mignot E. Immunogenetics 46:410-417(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*05:01). |
| [6] | "Ancient haplotypes of the HLA Class II region." Raymond C.K., Kas A., Paddock M., Qiu R., Zhou Y., Subramanian S., Chang J., Palmieri A., Haugen E., Kaul R., Olson M.V. Genome Res. 15:1250-1257(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:01; DQA1*01:02 AND DQA1*03:01). |
| [7] | "Four novel human leukocyte antigen-DQA1 alleles identified in the Korean population." Lee K.W., Jung Y.A., Oh D.H. Tissue Antigens 68:167-172(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:02; DQA1*05:06; DQA1*05:07 AND DQA1*05:08). |
| [8] | "Class II genes of the human major histocompatibility complex. Comparisons of the DQ and DX alpha and beta genes." Jonsson A.-K., Hyldig-Nielsen J.-J., Servenius B., Larhammar D., Andersson G., Joergensen F., Peterson P.A., Rask L. J. Biol. Chem. 262:8767-8777(1987) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*03:01). |
| [9] | "Identification of a novel DQA1 allele, DQA1*01012, and confirmatory sequence of DQA1*01011." Ashdown M.L., Leas L., Gavrilidis A., Wood J.M., Simons M.J. Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*01:01). |
| [10] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DQA1*02:01). |
| [11] | "New and confirmatory HLA sequences by SBT." Voorter C.E., van den Berg-Loonen E.M. Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:02 AND DQA1*05:09). |
| [12] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DQA1*01:01). Tissue: Trachea. |
| [13] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELES DQA1*01:02; DQA1*03:01 AND DQA1*05:01). |
| [14] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELES DQA1*03:01 AND DQA1*05:01). Tissue: Lymph. |
| [15] | "Sequence polymorphisms in HLA-DQA1 exon1." Yasunaga S., Kimura A., Sasazuki T. Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-27 (ALLELES DQA1*01:01/DQA1*01:02/DQA1*01:03; DQA1*01:04; DQA1*01:05; DQA1*02:01/DQA1*03:01/DQA1*03:03; DQA1*04:01/DQA1*06:01 AND DQA1*05:01/DQA1*05:03/DQA1*05:05). Tissue: B-cell. |
| [16] | "Nucleotide sequence of an HLA-DQ alpha chain derived from a DRw9 cell line: genetic and evolutionary implications." Moriuchi J., Moriuchi T., Silver J. Proc. Natl. Acad. Sci. U.S.A. 82:3420-3424(1985) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 19-254 (ALLELE DQA1*03:02). |
| [17] | "MHC class II sequences of an HLA-DR2 narcoleptic." Lock C.B., So A.K., Welsh K.I., Parkes J.D., Trowsdale J. Immunogenetics 27:449-455(1988) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 23-254 (ALLELE DQA1*01:02). |
| [18] | "Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM)." Yasunaga S., Kimura A., Hamaguchi K., Ronningen K.S., Sasazuki T. Tissue Antigens 47:37-48(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 24-250 (ALLELE DQA1*03:02/DQA1*03:03) AND NUCLEOTIDE SEQUENCE [MRNA] OF 24-249 (ALLELES DQA1*01:01; DQA1*01:03; DQA1*01:04; DQA1*04:01; DQA1*05:03; DQA1*05:05 AND DQA1*06:01). |
| [19] | Yasunaga S. Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 24-249 (ALLELE DQA1*01:05). |
| [20] | "Primary structure of human class II histocompatibility antigens 3rd communication. Amino acid sequence comparison between DR and DC subclass antigens derived from a lymphoblastoid B cell line homozygous at the HLA loci (HLA-A3,3; B7,7; Dw2,2; DR2,2: MT1,1; Dc1,1: MB1,1)." Goetz H., Kratzin H., Thinnes F.P., Yang C.-Y., Kruse T., Pauly E., Koelbel S., Egert G., Wernet P., Hilschmann N. Hoppe-Seyler's Z. Physiol. Chem. 364:749-755(1983) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 24-89; 102-120 AND 164-212 (ALLELE DQA1*01:02). |
| [21] | "Molecular analysis of the HLA class II genes in two DRw6-related haplotypes, DRw13 DQw1 and DRw14 DQw3." Kao H.T., Gregersen P.K., Tang J.C., Takahashi T., Wang C.Y., Silver J. J. Immunol. 142:1743-1747(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 24-209 (ALLELE DQA1*05:01). |
| [22] | "High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404." Cordovado S.K., Hancock L.N., Simone A.E., Hendrix M., Mueller P.W. Tissue Antigens 65:448-458(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELES DQA1*04:02 AND DQA1*04:04). |
| [23] | "Identification of a novel HLA-DQA1*06 allele detected by sequence-based typing." Simone A.E., Cordovado S.K., Hendrix M.M., Mueller P.W. Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELE DQA1*06:02). |
| [24] | "Identification of a novel HLA-DQA1*01 allele detected by sequence-based typing." Hancock L.N., Cordovado S.K., Mueller P.W. Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELE DQA1*01:07). |
| [25] | "Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals." Horn G.T., Bugawan T.L., Long C.M., Manos M.M., Erlich H.A. Hum. Immunol. 21:249-263(1988) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-110 (ALLELE DQA1*01:02), NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-109 (ALLELE DQA1*05:01). |
| [26] | "DQA1 subtyping in Australian Aborigines. Additional evidence for heterogeneity." Trejaut J.A., Greville W.D., Dunckley H. Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-109 (ALLELE DQA1*05:04). |
| [27] | "Identification of a novel HLA-DQA1 allele (DQA1*0106) by sequence-based DQA1 typing." Luo M., Blanchard J., Maclean I., Brunham R. Tissue Antigens 53:595-596(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 31-109 (ALLELE DQA1*01:06). |
| [28] | "HLA class II nucleotide sequences, 1992." Marsh S.G., Bodomer J.G. Tissue Antigens 40:229-243(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-74 (ALLELE DQA1*05:02). |
| [29] | "Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes." Liu C.P., Bach F.H., Wu S.K. J. Immunol. 140:3631-3639(1988) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 36-254 (ALLELE DQA1*05:01). |
| [30] | Erratum Liu C.P., Bach F.H., Wu S.K. J. Immunol. 144:15441-15441(1990) |
| [31] | "cDNA clone for the heavy chain of the human B cell alloantigen DC1: strong sequence homology to the HLA-DR heavy chain." Auffray C., Korman A.J., Roux-Dosseto M., Bono R., Strominger J.L. Proc. Natl. Acad. Sci. U.S.A. 79:6337-6341(1982) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 40-254 (ALLELE DQA1*03:01). |
| [32] | "Ancient roots for polymorphism at the HLA-DQ alpha locus in primates." Gyllensten U.B., Erlich H.A. Proc. Natl. Acad. Sci. U.S.A. 86:9986-9990(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-102 (ALLELE DQA1*05:01), NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-103 (ALLELE DQA1*01:02). |
| [33] | "Allelic forms of the alpha- and beta-chain genes encoding DQw1-positive heterodimers." Turco E., Care A., Compagnone-Post P., Robinson C., Cascino I., Trucco M. Immunogenetics 26:282-290(1987) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 119-254 (ALLELE DQA1*01:02). |
| [34] | "Invariant chain structure and MHC class II function." Cresswell P. Cell 84:505-507(1996) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [35] | "Presentation of antigens by MHC class II molecules: getting the most out of them." Villadangos J.A. Mol. Immunol. 38:329-346(2001) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [36] | "Autophagy in MHC class II presentation: sampling from within." Menendez-Benito V., Neefjes J. Immunity 26:1-3(2007) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [37] | "MHC class II molecules on the move for successful antigen presentation." Rocha N., Neefjes J. EMBO J. 27:1-5(2008) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [38] | "MHC class II transport at a glance." Berger A.C., Roche P.A. J. Cell Sci. 122:1-4(2009) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [39] | "CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract." Beswick E.J., Reyes V.E. World J. Gastroenterol. 15:2855-2861(2009) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [40] | "Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes." Lee K.H., Wucherpfennig K.W., Wiley D.C. Nat. Immunol. 2:501-507(2001) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 27-207 OF HLA-DQA1/HLA-DQB1 HETERODIMER IN COMPLEX WITH INS PEPTIDE, SUBUNIT, GLYCOSYLATION AT ASN-103, DISULFIDE BOND. |
| [41] | "Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy." Siebold C., Hansen B.E., Wyer J.R., Harlos K., Esnouf R.E., Svejgaard A., Bell J.I., Strominger J.L., Jones E.Y., Fugger L. Proc. Natl. Acad. Sci. U.S.A. 101:1999-2004(2004) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 24-219 OF HLA-DQA1/HLA-DQB1 HETERODIMER (HLA-DQ0602) IN COMPLEX WITH HCRT PEPTIDE, POLYMORPHISM, SUBUNIT, DISULFIDE BOND. |
| [42] | "Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease." Kim C.Y., Quarsten H., Bergseng E., Khosla C., Sollid L.M. Proc. Natl. Acad. Sci. U.S.A. 101:4175-4179(2004) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.22 ANGSTROMS) OF 24-216 OF HLA-DQA1/HLA-DQB1 HETERODIMER (DQ2) IN COMPLEX WITH TRITICUM AESTIVUM ALPHA/BETA-GLIADIN PEPTIDE, SUBUNIT, POLYMORPHISM. |
| [43] | "A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease." Henderson K.N., Tye-Din J.A., Reid H.H., Chen Z., Borg N.A., Beissbarth T., Tatham A., Mannering S.I., Purcell A.W., Dudek N.L., van Heel D.A., McCluskey J., Rossjohn J., Anderson R.P. Immunity 27:23-34(2007) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 24-206 OF HLA-DQA1/HLA-DQB1 HETERODIMER IN COMPLEX WITH TRITICUM AESTIVUM ALPHA/BETA-GLIADIN, SUBUNIT, DISULFIDE BOND. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X00033 mRNA. Translation: CAA24917.1. X00370 mRNA. No translation available. X00452 mRNA. Translation: CAA25141.1. M16995 mRNA. Translation: AAA59760.1. U92032 Genomic DNA. Translation: AAB91990.1. AY663395 Genomic DNA. Translation: AAU87978.1. AY663398 Genomic DNA. Translation: AAU87987.1. AY663400 Genomic DNA. Translation: AAU87992.1. AY663406 Genomic DNA. Translation: AAU88007.1. AY663411 Genomic DNA. Translation: AAU88022.1. AY663413 Genomic DNA. Translation: AAU88028.1. DQ178403 DQ178402 Genomic DNA. Translation: ABA86855.1.DQ178407 DQ178406 Genomic DNA. Translation: ABA86856.1.DQ178411 DQ178410 Genomic DNA. Translation: ABA86857.1.DQ178415 DQ178414 Genomic DNA. Translation: ABA86858.1.M29616, M29613 Genomic DNA. Translation: AAA59759.1. AF322870 AF322869 Genomic DNA. Translation: AAK11577.1.AF395700 AF395699 Genomic DNA. Translation: AAM69677.1.CR450297 mRNA. Translation: CAG29293.1. AM042559 Genomic DNA. Translation: CAJ14960.1. AM042560 Genomic DNA. Translation: CAJ14961.1. AK313975 mRNA. Translation: BAG36689.1. BX248406 Genomic DNA. Translation: CAM26191.1. AL662789 Genomic DNA. Translation: CAI18230.1. Z84489 Genomic DNA. Translation: CAB06491.1. BC008585 mRNA. Translation: AAH08585.1. BC157865 mRNA. Translation: AAI57866.1. L46875 mRNA. No translation available. L46876 mRNA. No translation available. L46877 mRNA. No translation available. L46878 mRNA. No translation available. L46880 mRNA. No translation available. L46881 mRNA. No translation available. M11124 mRNA. Translation: AAA59754.1. M20431 mRNA. Translation: AAA59758.1. L34082 mRNA. Translation: AAC41950.1. L34085 mRNA. Translation: AAC41953.1. L34086 mRNA. Translation: AAC41954.1. L34089 mRNA. Translation: AAC41957.1. L34090 mRNA. Translation: AAC41958.1. L34092 mRNA. Translation: AAC41960.1. L34093 mRNA. Translation: AAC41961.1. L34094 mRNA. Translation: AAC41962.1. L42625 mRNA. Translation: AAA85334.1. AY197775 Genomic DNA. Translation: AAO45622.1. AY547314 Genomic DNA. Translation: AAS49496.1. AY206406 Genomic DNA. Translation: AAO47362.1. AY585236 Genomic DNA. Translation: AAT09985.1. M34997 Genomic DNA. Translation: AAA35772.1. M34999 Genomic DNA. Translation: AAA74633.1. U85035 Genomic DNA. Translation: AAB41891.1. AF109734 Genomic DNA. Translation: AAD56720.1. Sequence problems. U03675 Genomic DNA. Translation: AAB60341.1. M20506 mRNA. Translation: AAA59774.1. J00199 mRNA. No translation available. M17846 mRNA. Translation: AAA59707.1. | ||||||||||||||||||||||||||||||||||||||||||
| IPI | IPI00976055. | ||||||||||||||||||||||||||||||||||||||||||
| PIR | HLHUD1. A02211. HLHUDQ. A02213. HLHUD7. A02214. HLHU3C. A02215. HLHUDC. A93326. B27628. D34512. | ||||||||||||||||||||||||||||||||||||||||||
| RefSeq | NP_002113.2. NM_002122.3. XP_003120317.1. XM_003120269.1. XP_003846794.1. XM_003846746.1. | ||||||||||||||||||||||||||||||||||||||||||
| UniGene | Hs.387679. Hs.591798. Hs.706240. | ||||||||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | P01909. | ||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||||||||
| IntAct | P01909. 10 interactions. | ||||||||||||||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||||||||||||||
| DMDM | 122188. | ||||||||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||||||||
| PaxDb | P01909. | ||||||||||||||||||||||||||||||||||||||||||
| PRIDE | P01909. | ||||||||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||||||||
| DNASU | 3117. | ||||||||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||||||||
| Ensembl | ENST00000343139; ENSP00000339398; ENSG00000196735. ENST00000374949; ENSP00000364087; ENSG00000196735. ENST00000383251; ENSP00000372738; ENSG00000206305. ENST00000395363; ENSP00000378767; ENSG00000196735. ENST00000395364; ENSP00000378768; ENSG00000196735. ENST00000399675; ENSP00000382583; ENSG00000206305. ENST00000399678; ENSP00000382586; ENSG00000206305. ENST00000418023; ENSP00000387892; ENSG00000232062. ENST00000444296; ENSP00000413237; ENSG00000232062. | ||||||||||||||||||||||||||||||||||||||||||
| GeneID | 100509457. 3117. | ||||||||||||||||||||||||||||||||||||||||||
| KEGG | hsa:100509457. hsa:3117. | ||||||||||||||||||||||||||||||||||||||||||
| UCSC | uc011fnq.1. human. | ||||||||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||||||||
| CTD | 3117. | ||||||||||||||||||||||||||||||||||||||||||
| GeneCards | GC06P032595. GC06Pn32538. GC06Po32698. | ||||||||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:4942. HLA-DQA1. | ||||||||||||||||||||||||||||||||||||||||||
| HPA | HPA012315. | ||||||||||||||||||||||||||||||||||||||||||
| MIM | 146880. gene. | ||||||||||||||||||||||||||||||||||||||||||
| neXtProt | NX_P01909. | ||||||||||||||||||||||||||||||||||||||||||
| PharmGKB | PA35066. | ||||||||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||||||||
| eggNOG | NOG26577. | ||||||||||||||||||||||||||||||||||||||||||
| HOVERGEN | HBG006862. | ||||||||||||||||||||||||||||||||||||||||||
| InParanoid | P04226. | ||||||||||||||||||||||||||||||||||||||||||
| KO | K06752. | ||||||||||||||||||||||||||||||||||||||||||
| OrthoDB | EOG4KWJTP. | ||||||||||||||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||||||||||||||
| Reactome | REACT_6900. Immune System. | ||||||||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||||||||
| ArrayExpress | P01909. | ||||||||||||||||||||||||||||||||||||||||||
| Bgee | P01909. | ||||||||||||||||||||||||||||||||||||||||||
| CleanEx | HS_HLA-DQA1. | ||||||||||||||||||||||||||||||||||||||||||
| Genevestigator | P01909. | ||||||||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||||||||
| Gene3D | 2.60.40.10. 1 hit. 3.10.320.10. 1 hit. | ||||||||||||||||||||||||||||||||||||||||||
| InterPro | IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR003006. Ig/MHC_CS. IPR003597. Ig_C1-set. IPR011162. MHC_I/II-like_Ag-recog. IPR014745. MHC_II_a/b_N. IPR001003. MHC_II_a_N. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||
| Pfam | PF07654. C1-set. 1 hit. PF00993. MHC_II_alpha. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||
| SMART | SM00407. IGc1. 1 hit. SM00920. MHC_II_alpha. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||
| SUPFAM | SSF54452. MHC_I/II-like_Ag-recog. 1 hit. | ||||||||||||||||||||||||||||||||||||||||||
| PROSITE | PS50835. IG_LIKE. 1 hit. PS00290. IG_MHC. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||||||||
| ChiTaRS | HLA-DQA1. human. | ||||||||||||||||||||||||||||||||||||||||||
| EvolutionaryTrace | P01909. | ||||||||||||||||||||||||||||||||||||||||||
| NextBio | 12366. | ||||||||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | DQA1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P01909 Secondary accession number(s): O19630 Q9UM31 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
